News

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
A Chinese company has developed a new diabetes drug that could become a strong competitor to Ozempic and Monjauro as a weight ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...
A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...